About [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate
[3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate (PubChem CID 69124217) has the molecular formula C27H29ClN4O6S
and a molecular weight of 573.07 g/mol. Its IUPAC name is [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate.
Molecular Properties
| Compound Name | [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate |
| PubChem CID | 69124217 |
| Molecular Formula | C27H29ClN4O6S |
| Molecular Weight | 573.07 g/mol |
| Exact Mass | 572.15 |
| IUPAC Name | [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate |
| SMILES | CC(C)(CCn1cnc2cc(Cl)c(OC(=O)O)cc21)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1 |
| InChI | InChI=1S/C27H29ClN4O6S/c1-27(2,11-12-32-17-29-22-14-21(28)25(15-23(22)32)38-26(34)35)30-16-24(33)18-7-6-8-19(13-18)31-39(36,37)20-9-4-3-5-10-20/h3-10,13-15,17,24,30-31,33H,11-12,16H2,1-2H3,(H,34,35)/t24-/m0/s1 |
| InChIKey | LGEJZFBOVWCYRP-DEOSSOPVSA-N |
| XLogP | 5.04 |
| TPSA | 142.78 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 573.07 |
| LogP ≤ 5 | 5.04 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phenyl_carbonate', 'substructure': 'N/A'} |
|---|
Analyze [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate?
The IUPAC name of [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate (CID 69124217) is [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate.
What is the SMILES notation for [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate?
The canonical SMILES for [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate is CC(C)(CCn1cnc2cc(Cl)c(OC(=O)O)cc21)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1.
What is the InChIKey of [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate?
The InChIKey is LGEJZFBOVWCYRP-DEOSSOPVSA-N. The full InChI is InChI=1S/C27H29ClN4O6S/c1-27(2,11-12-32-17-29-22-14-21(28)25(15-23(22)32)38-26(34)35)30-16-24(33)18-7-6-8-19(13-18)31-39(36,37)20-9-4-3-5-10-20/h3-10,13-15,17,24,30-31,33H,11-12,16H2,1-2H3,(H,34,35)/t24-/m0/s1.
What are the key properties of [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate?
[3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate has a molecular weight of 573.07 g/mol, XLogP of 5.04, 11 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[3-[[(2R)-2-[3-(benzenesulfonamido)phenyl]-2-hydroxyethyl]amino]-3-methylbutyl]-6-chlorobenzimidazol-5-yl] hydrogen carbonate is sourced from PubChem (CID 69124217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).